Resources

Navigating the New EU Clinical Trial Regulation: 536/2014

The European Clinical Trial Regulation 536/2014 (CTR) will be coming into full effect in 2022, and will significantly change how companies conduct their trials.

Are You Ready for your Qualified Persons Audit?

Many of our sponsor companies, have not had previous experience of European Union requirements for clinical trials or commercial products, in this session we will discuss the requirements of Qualified Person audits.

Importing Clinical Supplies into Eastern Europe

With a high access to patient pools, speedy patient recruitment and lower in-country costs compared to other regions, Eastern Europe continues to be a popular target for sponsors when running clinical trials.

Depot Selection and Management Strategy

Audio: Determining the best global supply strategy based upon the study design can be a complex discussion involving a number of variables depending upon the study design.

Ensuring Success in Your Package Design

Patient centric design and patient engagement, including graphic comprehension and elemental usability, coupled with end-to-end product protection require a robust design and development process.

EU Clinical Trials Regulations: The Impact of (CTR) No: 536/2014

AUDIO: our panel of industry experts walk you through a PCI Clinical Services watercooler chat discussing all the changes, benefits and potential disadvantages that the new EU Clinical Trial Regulation No 536/2014 will bring

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.